Low-level viraemia and virologic failure among people living with HIV who switched to coformulated bictegravir, emtricitabine and tenofovir alafenamide

被引：0
|
作者：
Chen, L. Y. [1 ]
Sun, H. Y. [2 ]
Liu, W. D. [2 ]
Chuang, Y. C. [2 ]
Chen, G. J. [2 ]
Wu, P. Y. [1 ]
Huang, C. W. [2 ]
Chang, H. Y. [1 ]
Luo, Y. Z. [1 ]
Su, Y. C. [2 ]
Liu, W. C. [2 ]
Chang, S. F. [3 ]
Chang, S. Y. [3 ]
Hung, C. C. [2 ]
机构：
[1] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
来源：
HIV MEDICINE | 2021年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
PE2/13
引用
收藏
页码：84 / 85
页数：2
相关论文
共 50 条
  • [1] Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens
    Chen, Guan-Jhou
    Sun, Hsin-Yun
    Chen, Ling-Ya
    Hsieh, Szu-Min
    Sheng, Wang-Hui
    Liu, Wang-Da
    Chuang, Yu-Chung
    Huang, Yu-Shan
    Lin, Kuan-Yin
    Wu, Pei-Ying
    Chang, Hsi-Yen
    Luo, Yu-Zhen
    Su, Yi-Ching
    Liu, Wen-Chun
    Chang, Sui-Fang
    Chang, Sui-Yuan
    Hung, Chien-Ching
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (03)
  • [2] Meta-Analysis of Efficacy and Safety of Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Among People Living with HIV
    I-Wen Chen
    Hsin-Yun Sun
    Chien-Ching Hung
    [J]. Infectious Diseases and Therapy, 2021, 10 : 1331 - 1346
  • [3] Meta-Analysis of Efficacy and Safety of Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Among People Living with HIV
    Chen, I-Wen
    Sun, Hsin-Yun
    Hung, Chien-Ching
    [J]. INFECTIOUS DISEASES AND THERAPY, 2021, 10 (03) : 1331 - 1346
  • [4] Breakthrough HIV viraemia on bictegravir/emtricitabine/tenofovir alafenamide in the third trimester of pregnancy
    Miller, Caragh
    Giguere, Pierre
    Mcguinty, Michaeline
    Angel, Jonathan Benjamin
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (09) : 2390 - 2391
  • [5] Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide
    Liou, Bo-Huang
    Cheng, Chih-Ning
    Lin, Ya-Ting
    Lin, Yu-Jou
    Chuang, Yu-Chung
    Lin, Kuan-Yin
    Liu, Wen-Chun
    Lin, Shu-Wen
    Kuo, Ching-Hua
    Sun, Hsin-Yun
    Hung, Chien-Ching
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 (11)
  • [6] Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamide
    Hsu, Jen-Yu
    Sun, Hsin-Yun
    Chen, Ling-Ya
    Chang, Sui-Yuan
    Chuang, Yu -Chung
    Huang, Yu -Shan
    Su, Yi-Ching
    Liu, Wen -Chun
    Hung, Chien -Ching
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2024, 36 : 426 - 435
  • [7] Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH)
    Gidari, Anna
    Benedetti, Sara
    Tordi, Sara
    Zoffoli, Anastasia
    Altobelli, Debora
    Schiaroli, Elisabetta
    De Socio, Giuseppe Vittorio
    Francisci, Daniela
    [J]. INFECTIOUS DISEASE REPORTS, 2023, 15 (06) : 766 - 777
  • [8] Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV
    Sellem, Baptiste
    Abdi, Basma
    Le, Minh
    Tubiana, Roland
    Valantin, Marc-Antoine
    Seang, Sophie
    Schneider, Luminita
    Faycal, Antoine
    Peytavin, Gilles
    Soulie, Cathia
    Marcelin, Anne-Genevieve
    Katlama, Christine
    Pourcher, Valerie
    Palich, Romain
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
  • [9] Comparative observational study of darunavir/cobicistat/emtricitabine/tenofovir alafenamide versus bictegravir/emtricitabine/tenofovir alafenamide in high-risk non-adherent people living with HIV
    Knobel, H.
    Canepa, C.
    Fernandez-Quiroga, M. J.
    Arrieta, I.
    Canas-Ruano, E.
    Villar, J.
    Guelar, A.
    Marcos, A.
    Guerri, R.
    Gonzalez, A.
    [J]. HIV MEDICINE, 2023, 24 : 82 - 83
  • [10] Real-world efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide in older people living with HIV
    Rolle, Charlotte-Paige
    Nguyen, Vu
    Patel, Kiran
    Cruz, Dan
    DeJesus, Edwin
    Hinestrosa, Federico
    [J]. MEDICINE, 2021, 100 (38)
12345